Cargando…
Myostatin blockage using actRIIB antagonism in mice bearing the Lewis lung carcinoma results in the improvement of muscle wasting and physical performance
BACKGROUND: Cachexia is a multiorganic syndrome associated with cancer, characterized by body weight loss, muscle and adipose tissue wasting and inflammation. METHODS: The aim of this investigation was to examine the effect of the soluble receptor antagonist of myostatin (sActRIIB) in cachectic tumo...
Autores principales: | Busquets, Sílvia, Toledo, Míriam, Orpí, Marcel, Massa, David, Porta, Maria, Capdevila, Eva, Padilla, Núria, Frailis, Valentina, López-Soriano, Francisco J., Han, H. Q., Argilés, Josep M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3302990/ https://www.ncbi.nlm.nih.gov/pubmed/22450815 http://dx.doi.org/10.1007/s13539-011-0049-z |
Ejemplares similares
-
Preliminary Investigation into a Potential Role for Myostatin and Its Receptor (ActRIIB) in Lean and Obese Horses and Ponies
por: Morrison, Philippa K., et al.
Publicado: (2014) -
Electrical impedance myography as a biomarker of myostatin inhibition with ActRIIB-mFc: a study in wild-type mice
por: Nagy, Janice A, et al.
Publicado: (2018) -
Akt Deficiency Attenuates Muscle Size and Function but Not the Response to ActRIIB Inhibition
por: Goncalves, Marcus D., et al.
Publicado: (2010) -
Identification of ligand-selective peptidic ActRIIB-antagonists using phage display technology
por: Sakamoto, Kotaro, et al.
Publicado: (2017) -
Blocking ActRIIB and restoring appetite reverses cachexia and improves survival in mice with lung cancer
por: Queiroz, Andre Lima, et al.
Publicado: (2022)